StemCells says its neural stem cells can prevent vision loss in lab rats
StemCells (Nasdaq:STEM), the Palo Alot biotech company, said Thursday that preclinical results for its product candidate HuCNS-SC, derived from human neural stem cells, were able to protect the retina from progressive degeneration when transplanted into lab rats.
“The HuCNS-SC cell has proven to have very robust survival, preserving vision in our rat model at time points beyond six months,” said Raymond Lund, a researcher and professor at the Casey Eye Institute at Oregon Health & Science University. “These data are very encouraging and suggest cell-based therapies for retinal degeneration can be a viable treatment approach.”
Shares of StemCells rose as much as 22 cents, or 22 percent, in Thursday trading after its news was released.
Subscribe via RSS all feeds